- Home
- GALT vs INGN Comparison
GALT vs INGN Comparison
Compare GALT & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GALT | INGN |
|---|---|---|
| Founded | 2000 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.2M | 172.4M |
| IPO Year | 2008 | 2013 |
Fundamental Metrics
Financial Performance| Metric | GALT | INGN |
|---|---|---|
| Price | $2.28 | $6.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $8.50 | ★ $11.25 |
| AVG Volume (30 Days) | 273.9K | ★ 315.0K |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 36.84 | ★ 43.42 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $348,668,000.00 |
| Revenue This Year | N/A | $8.03 |
| Revenue Next Year | N/A | $7.76 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.86 |
| 52 Week Low | $1.22 | $5.34 |
| 52 Week High | $7.13 | $9.13 |
Technical Indicators
Market Signals| Indicator | GALT | INGN |
|---|---|---|
| Relative Strength Index (RSI) | 45.56 | 43.16 |
| Support Level | $2.18 | $5.97 |
| Resistance Level | $2.60 | $6.93 |
| Average True Range (ATR) | 0.14 | 0.37 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 51.59 | 13.08 |
Price Performance
Historical ComparisonAbout GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About INGN Inogen Inc
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.